Abstract：Objective To study the clinical effect of recombinant bovine basic fibroblast growth factor gel in aid therapy of eczema.Methods A total of 76 eczema children treated from March 2017 to September 2018 in our hospital were selected.Patients were divided into the control group and the research group according to random number table method, 38 cases in each group.The control group just took compound boric acid and zinc oxide ointment; on the basis of the former, the research group took recombinant bovine basic fibroblast growth factor gel.The onset time, cured time,therapeutic effect and disease assessment scores were compared between two groups.Results Before treatment, the disease assessment scores between groups were not significantly different (P＞0.05）; after 2 and 4 w of treatment, related scores in the research group were lower than those of control group; after 2 and 4 w of treatment, related scores for two groups were lower than that of before treatment (P<0.05）.The onset time, symptom relief time and cured time in the research group was shorter than those of control group; the total effective rate in the research group (94.74%) was significantly higher than that of control group (78.95%), the differences were statistically significant (P<0.05）.Conclusion The recombinant bovine basic fibroblast growth factor gel produces a synergistic effect in eczema children, can shorten the onset time and increase the clinical efficacy.It is worthy of clinical promotion and application.
米宁; 邓微. 重组牛碱性成纤维细胞生长因子凝胶辅助治疗湿疹的临床效果[J]. 中国当代医药, 2019, 26(18): 93-95.
MI Ning; DENG Wei. Clinical effect of recombinant bovine basic fibroblast growth factor gel in the treatment of eczema. 中国当代医药, 2019, 26(18): 93-95.
京公网安备 11010502046607号